Table 3.
Estimated pharmacodynamic parameters describing the suppressant effect on plasma DHT concentration by TF-505 after single doses 25–100mg.
| Dose (mg) | kin (% h-1) | CV (%) | kout (h-1) | CV (%) | Ic50 (µg ml-1) | CV (%) |
|---|---|---|---|---|---|---|
| 25 | 17.82 | 27.59 | 0.17 | 27.01 | 0.82 | 24.66 |
| 50 | 17.38 | 22.01 | 0.16 | 20.73 | 1.48 | 19.78 |
| 75 | 17.03 | 23.09 | 0.17 | 22.23 | 1.31 | 21.00 |
| 100 | 10.70 | 17.88 | 0.10 | 16.30 | 0.88 | 21.73 |
kin, zero-order rate constant for appearance of suppressant effect on plasma DHT concentration; kout, first-order rate constant for disappearance of suppressant effect on plasma DHT concentration; IC50, TF-505 plasma concentration producing half of maximum kin inhibition. Estimates of interindividual variability are expressed as CV, coefficient of variation (%).